title: Survivin and pancreatic cancer.
abstract: Pancreatic cancer is estimated to be the fourth most common cancer in men and fifth in women in the world and has poor prognosis. In recent years, more and more effort has been put on the relationship between pancreatic cancer and apoptosis. As a newly discovered inhibitor of apoptosis, survivin has drawn more attention. Strong evidence has shown that survivin is expressed in pancreatic cancer cells on frozen sections. Survivin increases in the development of pancreatic ductal adenocarcinoma and its expression can be a marker in evaluating the prognosis of pancreatic cancer patients. Survivin itself may be a new target in the treatment of pancreatic cancer and a survivin DNA vaccine could generate specific antitumor effects in pancreatic carcinoma models.
authors: Bin-Bin Liu, Wei-Hong Wang, Department of Gastroenterology, Peking University First Hospital, Beijing 100034, China.
authors: Bin-Bin
authors: BB
authors: Liu
authors: Wei-Hong
authors: WH
authors: Wang
references: Pancreas. 2010 Oct;39(7):976-80
references: 20357690
references: Cancer Res. 2004 Jan 1;64(1):337-46
references: 14729643
references: J Cell Sci. 2002 Feb 1;115(Pt 3):575-85
references: 11861764
references: Am J Clin Pathol. 2006 Oct;126(4):572-9
references: 17019794
references: Cancer Immunol Immunother. 2006 Oct;55(10):1294-8
references: 16315030
references: J Gastroenterol Hepatol. 2005 Oct;20(10):1595-602
references: 16174080
references: Nat Med. 1997 Aug;3(8):917-21
references: 9256286
references: Am J Pathol. 1998 Jan;152(1):43-9
references: 9422522
references: Br J Cancer. 2002 Mar 18;86(6):886-92
references: 11953819
references: Cancer Res. 1998 Dec 1;58(23):5315-20
references: 9850056
references: Dig Dis Sci. 2009 Jan;54(1):89-96
references: 18594980
references: Cancer Biol Ther. 2005 May;4(5):561-70
references: 15917666
references: Int J Gastrointest Cancer. 2002;32(2-3):73-81
references: 12794243
references: Cancer Res. 2003 Oct 15;63(20):6815-24
references: 14583479
references: World J Gastroenterol. 2006 May 14;12(18):2901-7
references: 16718816
references: Curr Biol. 2000 Nov 2;10(21):1319-28
references: 11084331
references: BMC Cancer. 2005 Oct 04;5:127
references: 16202147
references: Nature. 2001 May 17;411(6835):390-5
references: 11357148
references: Am J Pathol. 2004 Jul;165(1):181-9
references: 15215174
references: J Clin Invest. 2004 Oct;114(8):1117-27
references: 15489959
references: Vaccine. 2007 Nov 14;25(46):7955-61
references: 17933439
references: Surgery. 2004 Aug;136(2):443-8
references: 15300213
references: Br J Cancer. 2005 Jun 20;92(12):2225-32
references: 15928668
references: Jpn J Cancer Res. 2000 Nov;91(11):1204-9
references: 11092988
references: Oncol Rep. 2009 Sep;22(3):557-62
references: 19639203
references: Surgery. 2005 Aug;138(2):299-305
references: 16153440
references: Neuroendocrinology. 2005;81(1):1-9
references: 15809513
references: Am J Surg Pathol. 2006 Jun;30(6):754-9
references: 16723855
references: Cancer. 2001 Jul 15;92(2):271-8
references: 11466679
references: Jpn J Cancer Res. 2002 Sep;93(9):1057-62
references: 12359060
references: J Biol Chem. 2007 Nov 30;282(48):35018-23
references: 17881355
references: Hepatobiliary Pancreat Dis Int. 2010 Feb;9(1):69-77
references: 20133233
references: Anticancer Res. 2005 Nov-Dec;25(6B):3967-72
references: 16309185
references: Chin Med Sci J. 2006 Jun;21(2):115-9
references: 16845800